Consolidated Statements of Cash Flow - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Operating activities:
Net loss	$ (18,369,810)	$ (1,364,518)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, Total	110,371	67,981
Stock-based compensation expense	1,221,591	1,240,551
Common stock issued for advisory services	50,000	50,000
Warrant related expense, change in fair value, and other financing expenses		(8,976,250)
Change in deferred income taxes	(437,289)	(1,055,685)
Goodwill impairment	6,929,258
Non-cash interest expense, net		33,517
Changes in operating assets and liabilities:
Prepaid expenses, deposits and other assets	(1,102)	(664,162)
Accounts payable, accrued expenses and other liabilities	(275,835)	(1,663,789)
Net cash used in operating activities	(10,772,816)	(12,332,355)
Cash flows used in investing activities:
Purchases of property and equipment		(447,823)
Purchases of certificates of deposit		(10,000,000)
Maturities of certificates of deposit		10,000,000
Net cash used in investing activities		(447,823)
Cash flows provided by financing activities:
Proceeds from sale of common stock	10,846,062
Proceeds from the sale of Series A convertible preferred stock and warrants, net		22,129,774
Repayment of convertible debt	(550,000)	(1,880,000)
Payment of offering costs	(428,542)	(125,980)
Net cash provided by financing activities	9,867,520	20,123,794
Net (decrease) increase in cash and cash equivalents	(905,296)	7,343,616
Cash and cash equivalents at beginning of year	8,896,468	1,552,852
Cash and cash equivalents at end of year	7,991,172	8,896,468
Supplemental disclosure of cash flow information:
Cash paid for interest	40,142	112,800
Supplemental disclosure of non-cash investing and financing activities:
Reclassification of accrued dividends related to the issuance of common stock to Series A convertible preferred stock holders	1,148,307
Reclassification of the fair market value of the Series A warrants		13,153,524
Series A cumulative preferred dividends	85,993	1,252,394
Conversion of accrued dividends related to convertible preferred stock		190,080
Offering costs in accounts payable and accrued expenses		$ 146,776